Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature

Overview

Journal Curr Neurol Neurosci Rep

Specialty Neurology

Date 2022 Feb 2

PMID 35107785

Authors

Jessica Frey

Irene A Malaty

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: This study aims to examine the treatments currently available for Tourette syndrome (TS) and to discuss evolving therapies, spanning behavioral, pharmacologic, complementary and alternative medicine, and neuromodulation approaches.

Recent Findings: Behavioral therapies have undergone several modifications to improve accessibility, including transitioning to a virtual format which is particularly important in the current pandemic. There are several recent or ongoing pharmacologic studies that have shown promise including the selective D1 receptor antagonist ecopipam and various cannabinoid compounds. Adaptive DBS may enable the physiologic markers of tics to determine stimulation parameters and improve tic outcomes related to neuromodulation. In recent years, there has been a wealth of research across multiple treatment domains in the TS field. This review highlights exciting and new potential options for the future treatment of patients with TS.

Citing Articles

Neuroinflammation and pathways that contribute to tourette syndrome.

Wu X, Hao J, Jiang K, Wu M, Zhao X, Zhang X Ital J Pediatr. 2025; 51(1):63.

PMID: 40022157 PMC: 11871796. DOI: 10.1186/s13052-025-01874-3.

Therapeutic Approach to Primary Tic Disorders and Associated Psychiatric Comorbidities.

Berzosa-Gonzalez I, Martinez-Horta S, Perez-Perez J, Kulisevsky J, Pagonabarraga J Brain Sci. 2025; 14(12.

PMID: 39766430 PMC: 11726857. DOI: 10.3390/brainsci14121231.

Emerging therapeutic approaches for Tourette syndrome and other tic disorders - a systematic review of current clinical trials.

Hage A, Kramer R, Dunlap M, Mechler K, Muller-Vahl K, Nagy P Eur Child Adolesc Psychiatry. 2024; .

PMID: 39714607 DOI: 10.1007/s00787-024-02637-x.

Impacts of ADHD Symptomatology on the Response to Cognitive-Behavioural Therapy with Gilles de la Tourette Syndrome Patients.

Mazur-Laine E, Soubata H, B Leclerc J, Blanchet P, OConnor K, Lavoie M J Clin Med. 2024; 13(10).

PMID: 38792517 PMC: 11122476. DOI: 10.3390/jcm13102975.

An Update on the Diagnosis and Management of Tic Disorders.

Desai I, Kumar N, Goyal V Ann Indian Acad Neurol. 2024; 26(6):858-870.

PMID: 38229610 PMC: 10789408. DOI: 10.4103/aian.aian_724_23.

References

. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002; 58(4):527-36. DOI: 10.1212/wnl.58.4.527. View

Xu W, Zhang C, Deeb W, Patel B, Wu Y, Voon V . Deep brain stimulation for Tourette's syndrome. Transl Neurodegener. 2020; 9:4. PMC: 6956485. DOI: 10.1186/s40035-020-0183-7. View

Wu S, Maloney T, Gilbert D, Dixon S, Horn P, Huddleston D . Functional MRI-navigated repetitive transcranial magnetic stimulation over supplementary motor area in chronic tic disorders. Brain Stimul. 2013; 7(2):212-8. DOI: 10.1016/j.brs.2013.10.005. View

Diamond A, Kenney C, Jankovic J . Effect of vagal nerve stimulation in a case of Tourette's syndrome and complex partial epilepsy. Mov Disord. 2006; 21(8):1273-5. DOI: 10.1002/mds.20949. View

Nagai Y, Cavanna A, Critchley H . Influence of sympathetic autonomic arousal on tics: implications for a therapeutic behavioral intervention for Tourette syndrome. J Psychosom Res. 2009; 67(6):599-605. DOI: 10.1016/j.jpsychores.2009.06.004. View

Viefhaus P, Feldhausen M, Gortz-Dorten A, Volk H, Dopfner M, Woitecki K . Efficacy of Habit Reversal Training in Children With Chronic Tic Disorders: A Within-Subject Analysis. Behav Modif. 2018; 44(1):114-136. DOI: 10.1177/0145445518796203. View

Tao D, Zhong T, Ma S, Li J, Li X . Randomized controlled clinical trial comparing the efficacy and tolerability of aripiprazole and sodium valproate in the treatment of Tourette syndrome. Ann Gen Psychiatry. 2019; 18:24. PMC: 6785853. DOI: 10.1186/s12991-019-0245-3. View

Himle M, Freitag M, Walther M, Franklin S, Ely L, Woods D . A randomized pilot trial comparing videoconference versus face-to-face delivery of behavior therapy for childhood tic disorders. Behav Res Ther. 2012; 50(9):565-70. DOI: 10.1016/j.brat.2012.05.009. View

Artukoglu B, Bloch M . The Potential of Cannabinoid-Based Treatments in Tourette Syndrome. CNS Drugs. 2019; 33(5):417-430. DOI: 10.1007/s40263-019-00627-1. View

10.

Mantovani A, Lisanby S, Pieraccini F, Ulivelli M, Castrogiovanni P, Rossi S . Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS). Int J Neuropsychopharmacol. 2005; 9(1):95-100. DOI: 10.1017/S1461145705005729. View

11.

Verdellen C, Keijsers G, Cath D, Hoogduin C . Exposure with response prevention versus habit reversal in Tourettes's syndrome: a controlled study. Behav Res Ther. 2004; 42(5):501-11. DOI: 10.1016/S0005-7967(03)00154-2. View

12.

Scahill L, Chappell P, Kim Y, Schultz R, Katsovich L, Shepherd E . A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry. 2001; 158(7):1067-74. DOI: 10.1176/appi.ajp.158.7.1067. View

13.

Gulisano M, Cali P, Cavanna A, Eddy C, Rickards H, Rizzo R . Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome. Neurol Sci. 2011; 32(6):1213-7. DOI: 10.1007/s10072-011-0678-1. View

14.

Jakubovski E, Reichert C, Karch A, Buddensiek N, Breuer D, Muller-Vahl K . The ONLINE-TICS Study Protocol: A Randomized Observer-Blind Clinical Trial to Demonstrate the Efficacy and Safety of Internet-Delivered Behavioral Treatment for Adults with Chronic Tic Disorders. Front Psychiatry. 2016; 7:119. PMC: 4928510. DOI: 10.3389/fpsyt.2016.00119. View

15.

Okun M, Foote K, Wu S, Ward H, Bowers D, Rodriguez R . A trial of scheduled deep brain stimulation for Tourette syndrome: moving away from continuous deep brain stimulation paradigms. JAMA Neurol. 2012; 70(1):85-94. DOI: 10.1001/jamaneurol.2013.580. View

16.

Ackermans L, Duits A, Van der Linden C, Tijssen M, Schruers K, Temel Y . Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome. Brain. 2011; 134(Pt 3):832-44. DOI: 10.1093/brain/awq380. View

17.

McGuire J, Piacentini J, Scahill L, Woods D, Villarreal R, Wilhelm S . Bothersome tics in patients with chronic tic disorders: Characteristics and individualized treatment response to behavior therapy. Behav Res Ther. 2015; 70:56-63. PMC: 4449823. DOI: 10.1016/j.brat.2015.05.006. View

18.

Carvalho S, Goncalves O, Soares J, Sampaio A, Macedo F, Fregni F . Sustained Effects of a Neural-based Intervention in a Refractory Case of Tourette Syndrome. Brain Stimul. 2015; 8(3):657-9. DOI: 10.1016/j.brs.2014.12.008. View

19.

Mrakic-Sposta S, Marceglia S, Mameli F, Dilena R, Tadini L, Priori A . Transcranial direct current stimulation in two patients with Tourette syndrome. Mov Disord. 2008; 23(15):2259-61. DOI: 10.1002/mds.22292. View

20.

B Leclerc J, OConnor K, J-Nolin G, Valois P, Lavoie M . The Effect of a New Therapy for Children with Tics Targeting Underlying Cognitive, Behavioral, and Physiological Processes. Front Psychiatry. 2016; 7:135. PMC: 4980689. DOI: 10.3389/fpsyt.2016.00135. View